Comparison of Various Hematopoietic Stem Cell Mobilization Regimens in Patients with Lymphoma and Myeloma
CLINICAL LABORATORY, cilt.65, sa.10, ss.1845-1852, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 65 Sayı: 10
- Basım Tarihi: 2019
- Doi Numarası: 10.7754/clin.lab.2019.190214
- Dergi Adı: CLINICAL LABORATORY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1845-1852
- Anahtar Kelimeler: lymphoma, myeloma, stem cell mobilization, IEV regimen, COLONY-STIMULATING FACTOR, HIGH-DOSE CYCLOPHOSPHAMIDE, BLOOD PROGENITOR-CELL, G-CSF, MULTIPLE-MYELOMA, MOBILIZING REGIMEN, SALVAGE THERAPY, ETOPOSIDE, IFOSFAMIDE, TRANSPLANTATION
- Akdeniz Üniversitesi Adresli: Evet
Özet
Background: The aim of this study was to evaluate the efficacy of cyclophosphamide-based (CB) and platinum-based (PB) chemotherapy regimens for hematopoietic stem cell mobilization in patients with Multiple Myeloma (MM), Hodgkin's lymphoma (HL), and non-Hodgkin's lymphoma (NHL) and the less well-known IEV (iphosphamide, epirubicin, etoposide) regimen in terms of stem cell harvesting competence, factors affecting stem cell competence, and toxicity.